Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy

紫杉醇 姜黄素 体内 药理学 细胞凋亡 体外 药物输送 细胞毒性 化疗 化学 癌症研究 医学 内科学 生物化学 生物 生物技术 有机化学
作者
Kang Xiong,Yan Zhang,Qian Wen,Jia Luo,Yun Lü,ZhouXue Wu,BiQiong Wang,Yue Chen,Ling Zhao,Shaozhi Fu
出处
期刊:International Journal of Pharmaceutics [Elsevier BV]
卷期号:589: 119875-119875 被引量:63
标识
DOI:10.1016/j.ijpharm.2020.119875
摘要

Multi-drug chemotherapy has been one of the most popular strategies for the treatment of malignant tumors, and has achieved desirable therapeutic outcomes. The objective of the present study is to develop biodegradable PCEC nanoparticles (NPs) for the co-delivery of paclitaxel (PTX) and curcumin (CUR), and investigate the antitumor effect of the drug delivery system (DDS: PTX-CUR-NPs) against breast cancer both in vitro and in vivo. The prepared PTX-CUR-NPs had a small size of 27.97 ± 1.87 nm with a low polydispersity index (PDI, 0.197 ± 0.040). The results exhibited slow release of PTX and CUR from the DDS without any burst effect. Further, the PTX-CUR-NPs displayed a dose-dependent cytotoxicity in MCF-7 cells with a higher apoptosis rate (64.29% ± 1.97%) as compared to that of free drugs (PTX + CUR, 34.21% ± 0.81%). The cellular uptake study revealed that the drug loaded PCEC polymeric nanoparticles were more readily uptaken by tumor cells in vitro. To evaluate the in vivo anti-tumor effect, the PTX-CUR-NPs were intravenously administered to BALB/c nude mouse xenografted with MCF-7 cells and the results exhibited significant inhibition of tumor growth with prolonged survival time and reduced side effect when compared with free drugs (PTX + CUR). Moreover, the administration of PTX-CUR-NPs treatment led to lower Ki67 expression (p < 0.05), and enhanced TUNEL positivity (higher apoptosis, p < 0.01) in tumor cells as compared to other treatment groups, suggesting the therapeutic efficacy of the DDS. Altogether, the present study suggests that the DDS PTX-CUR-NPs could be employed for the effective treatment of breast cancers in near future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可靠的纸鹤完成签到,获得积分10
1秒前
1秒前
1秒前
wanci的应助被Valley采纳,获得10
1秒前
HJC发布了新的文献求助10
1秒前
田夜发布了新的文献求助10
1秒前
紫杉罗罗完成签到,获得积分10
1秒前
lucky完成签到,获得积分10
1秒前
张云涛关注了科研通微信公众号
1秒前
科研通AI2S的应助被勤奋无剑采纳,获得10
2秒前
舒服的尔曼完成签到,获得积分10
2秒前
朝巷完成签到,获得积分10
2秒前
2秒前
芒果个冉冉完成签到,获得积分10
2秒前
zhou发布了新的文献求助10
3秒前
SenyngChen完成签到,获得积分10
3秒前
星辰大海的应助被顺心人达采纳,获得10
4秒前
4秒前
威武大将军完成签到,获得积分10
4秒前
Bonny完成签到,获得积分10
4秒前
隐形曼青的应助被XKY采纳,获得10
4秒前
打打的应助被YANG采纳,获得10
5秒前
5秒前
研友_enP05n完成签到,获得积分0
5秒前
fortuna发布了新的文献求助10
5秒前
5秒前
6秒前
科研汪星人完成签到,获得积分10
6秒前
6秒前
orixero的应助被黑粉头头采纳,获得10
6秒前
Yangbingang发布了新的文献求助10
7秒前
7秒前
一叶孤舟完成签到,获得积分10
7秒前
小牛同志完成签到,获得积分10
7秒前
7秒前
芝芝莓莓完成签到,获得积分10
7秒前
Limerence完成签到,获得积分10
7秒前
xbaggio完成签到,获得积分10
8秒前
莲花盛开完成签到,获得积分0
8秒前
Eileen完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159633
求助须知:如何正确求助?哪些是违规求助? 9555145
关于积分的说明 21725138
捐赠科研通 7749593
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552345
邀请新用户注册赠送积分活动 2471619